Jeremy Rura joined the MJ team as an analytics intern on the Risk Management + Commercial Insurance team during his undergraduate education. When he rejoined the team, he assumed the role of senior analyst in our Benefits Consulting department. He collaborates closely with our valued clients to understand their strategic goals and provide them with actionable insights from our proprietary analytics platform, APERTURE®.
During his time as an analytics intern at MJ, Jeremy led a project to design a dashboard that tracked property line coverage within the first month of his internship. This project provided valuable, enterprise-wide insights. This experience, coupled with his academic background, has developed Jeremy into a skilled analyst with a strong ability to identify trends in claims data. His data-driven mindset makes him an immense value add to our team.
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
The Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
For years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Volatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
On Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
The U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More